Applications of the Insieme Platform: A Case Study

Primož Kocuvan, Erik Dovgan, Simon Ražman, Devid Palčič, Matjaž Gams

Abstract


The information society has significantly changed the field of medicine. Several decades ago when a person got sick, a doctor examined a patient and prescribed some medicine with a patient more or less unaware of the true nature of the problem. Even if explained, many patients did not understand much due to the lack of medical knowledge. Today, knowledge is widely accessible through the web and many patients try to self-diagnose or at least get another opinion using popular search engines and specialized web applications. However, many of them provide misinformation due to the lack of proper education of the provider or the lack of understanding of the user. To overcome these issues, we developed a verified medical platform (Insieme platform) that includes medical data, applications and services. This article provides a list of applications in the Insieme platform, their descriptions and how to use them.


Full Text:

PDF

References


ISE-EMH project, Insieme platform, https://ise-emh.eu/. Accessed July 11, 2022.

EkoSMART, https://feri.um.si/raziskovanje/ mednarodni-projekti-in-projekti-strukturnih-skladov/ekosistem-pametnega-mesta/. Accessed July 11, 2022.

Clynx, Motiphy+ application, https://www.clynx.io/. Accessed May 10, 2022.

Robotina, HEMS, https://mailchi.mp/robotina/ise-emh_elderly_hems_data_services. Accessed May 10, 2022.

DaVinci Biolab app, DaVinci, https://davinci.biohub.solutions/. Accessed May 10, 2022.

Platomics, Platomics application Biolab, https://davinci.biohub.solutions/platomics/. Accessed May 10, 2022.

Depression application MoodTools, https://www.moodtools.org/. Accessed May 10, 2022.

Narcistic personal disorder test, Do I have a personal disorder?, https://www.therecoveryvillage.com/mental-health/personality-disorders/do-i-have-a-personality-disorder/. Accessed May 10, 2022.

Bigorexia, Body dysmphorphia quiz, https://eatingdisordersolutions.com/body-dysmorphic-eating-disorder-treatment/body-dysmorphia-quiz/. Accessed May 10, 2022.

Schizophrenia self-testing app, https://www.mind-diagnostics.org/schizophrenia-test. Accessed May 10, 2022.

Focus on Lymphoma web application, https://www.digiteum.com/portfolio/no-1-healthcare-app-for-lymphoma/. Accessed May 10, 2022.

Clayman Thyroid Center, Thyroid cancer application, https://www.thyroidcancer.com/app. Accessed May 10, 2022.

ASPO, https://aspo.mf.uni-lj.si/static/ASPO_new/#/. Accessed May 10, 2022.

HEP-Y, https://hepy.mf.uni-lj.si/static/HEPY_new/# /opisi-virusnihhepatitisov/description-hb. Accessed May 10, 2022.

Senior helper application for elderly, http://senior-helper-website.docker-e9.ijs.si/. Accessed May 10, 2022.

Nala-care, Neuro-dermatitis app, https://nala.care/en/. Accessed May 10, 2022.

Skin-vision, Skin cancer melanoma application, https://www.skinvision.com/. Accessed May 10, 2022.

SURS, Število in sestava prebivalstva, https://www.stat.si/StatWeb/Field/Index/17/104. Accessed May 10, 2022.

United nations, Our world is growing older, https://www.un.org/development/desa/en/news/population/our-world-is-growing-older.html. Accessed May 10, 2022.

A. J. Astell, M. Panouand K. Touliou, et al. (2022). Developing a pragmatic evaluation of ICTs for older adults with cognitive impairment at scale: the IN LIFE experience. Univ Access Inf Soc, vol. 21, pp. 1–19, https://doi.org/10.1007/s10209-021-00849-5.

J. Bizjak, A. Gradišek, L. Stepančič, H. Gjoreski, and M. Gams (2017). Intelligent assistant carer for active aging. EURASIP J. Adv. Signal Process, vol. 2017, no. 76, https://doi.org/10.1186/s13634-017-0511-y.

R. I. Putu. (2020). Integrated Scada-Tricoder: A Modern Hospital Room. https://doi.org/10.13140/RG.2.2.24385.38247.

N. M. Pereira-Azevedo and L. D. F. Venderbos (2018). eHealth and mHealth in prostate cancer detection and active surveillance. Transl Androl Urol, vol. 7, no. 1, pp. 170–181, https://doi.org/10.21037/tau.2017.12.22.

N. Pereira-Azevedo, J. F. M. Verbeek, D. Nieboer, C. H. Bangma, and M. J. Roobol (2018). Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome. Transl Androl Urol, vol. 7, no. 1, pp. 18–26, https://doi.org/10.21037/tau.2017.12.21.

N. Pereira-Azevedo, L. Osório, A. Fraga, and M. J. Roobol (2017). Rotterdam prostate cancer risk calculator: development and usability testing of the mobile phone app. JMIR Cancer, vol.3 no. 1, article no. e1, https://doi.org/10.2196/cancer.6750.

ScienceDaily, University of East Anglia, Prostate cancer urine test identifies good prognosis patients, www.sciencedaily.com/releases/2021/11/211102210147.htm. Accessed May 10, 2022.

D. Ilic, M. Djulbegovic, J. H. Jung, E. C. Hwang, Q. Zhou, A. Cleves, T. Agoritsas, and P. Dahm (2018). Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ, vol. 362, article no. k3519, https://doi.org/10.1136/bmj.k3519.

S. M. Lenherr and J. Quentin Clemenm (2013). Urodynamics: with a focus on appropriate indications. Urol Clin North Am, vol. 40, no. 4, pp. 545–557, https://doi.org/10.1016/j.ucl.2013.07.001.

C. J. Harvey, J. Pilcher, J. Richenberg, U. Patel, and F. Frauscher (2012). Applications of transrectal ultrasound in prostate cancer. Br J Radiol, vol. 85, pp. S3–S17, https://doi.org/10.1259/bjr/56357549.

S. F. Shariat and C. G. Roehrborn (2008). Using biopsy to detect prostate cancer. Rev Urol, vol. 10, no. 4, pp. 262–280.

Frequency of urinating, https://www.bladderandbowel.org/bladder/bladder-conditions-and-symptoms/frequency/. Accessed May 10, 2022.

A. Ajanović, J. Konda, G. Fele-Žorž, A. Gradišek, M. Gams, A. Peterlin, K. Počivavšek, M. Matičič (2017). Application for sexually transmitted infection risk assessment. Informatica, vol. 41, no. 2, pp. 253–254.

A. Ajanović, A. Ulčar, A. Petelin, K. Počivavšek, G. Fele-Žorž, A. Gradišek, M. Gams, and M. Matičič (2018). Application for viral hepatitis infection risk assessment - HEPY. Informatica, vol. 42, no. 2, pp. 279–281.




DOI: https://doi.org/10.31449/inf.v46i4.4210

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.